Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Revenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit increased mainly due to the recognition of gains on the sale of investment securities.
Not applicable
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥29,851 million (YoY -1.0%) |
| Operating profit | ¥5,193 million (YoY +8.1%) |
| Ordinary income | ¥6,179 million (YoY +7.7%) |
| Profit attributable to owners of the parent | ¥6,443 million (YoY +32.3%) |
| Net income per share | ¥203.49 |
| Equity ratio | End of the current fiscal period 65.9 / End of previous period 63.8 |
| Total assets | ¥154,714 million |
| Net assets | ¥104,128 million |
| Full-year earnings forecast | Net Sales ¥41,100 million (YoY +1.1%) / Operating profit ¥5,800 million (YoY -0.9%) / Ordinary income ¥7,200 million (YoY -0.2%) / Net income ¥7,450 million (YoY +29.3%) |
| Annual Dividend Forecast | 60 Yen → 70 Yen |
| Segment revenue | Real Estate ¥9,080 million (YoY +4.5%), Pharmaceuticals ¥8,856 million (YoY +5.3%), Machinery-related ¥4,802 million (YoY -22.8%), Textiles ¥5,119 million (YoY +5.7%), Other ¥1,992 million (YoY +1.0%) |
| Segment profit | Real Estate ¥3,817 million (YoY +10.6%), Pharmaceuticals ¥723 million (YoY -11.8%), Machinery-related ¥388 million (YoY -45.8%), Textiles ¥835 million (YoY +68.0%), Other ¥87 million (YoY +81.5%) |
| Depreciation and amortization | ¥2,156 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥2,973 million / Extraordinary loss Loss on disposal of fixed assets ¥76 million |
| Disclosure regarding the going concern assumption | Not applicable |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not applicable |
| Material subsequent events | No applicable items |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | None (対象者:Not disclosed) |
| Issued Shares at Period-End | 35,215,000 Shares |
| Treasury Shares at Period-End | 3,543,011 Shares |
| Factors Behind Changes in Business Performance | Revenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit increased mainly due to the recognition of gains on the sale of investment securities. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue declined due to lower revenue from the machinery-related business, despite higher revenue from the real estate and pharmaceutical businesses, among others. Operating profit increased, as higher profit from the real estate and textile businesses, among others, outweighed lower profit from the machinery-related and pharmaceutical businesses. Net profit attributable to owners of the parent increased, mainly due to the recognition of gains on the sale of investment securities. This brief report does not provide details on the reasons for revising the dividend forecast.